| « Prescriptions flagged as risky in new list | Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R ... » |
Link: http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2008/09/05/MN2B12OSAS.DTL
FDA posts list of potential problem drugs San Francisco Chronicle, USA - 7 hours ago Revlimid, for multiple myeloma, severe skin blistering and bleeding. -- Nitrostat, for angina, overdose due to labeling confusion.